Keyphrases
1-year Mortality
11%
All-cause Mortality
22%
Beneficial Effects
11%
Clinical Benefit
11%
Ejection Fraction
11%
Group-based
11%
Hospitalization
22%
Inflammation
11%
Mortality Risk
11%
No Significant Difference
11%
Pathogenic Mechanism
11%
Patient-centered
11%
Pleiotropic Effects
11%
Preserved Left Ventricular Function
22%
Propensity Score Matching
22%
Propensity Score Matching Study
100%
Pulmonary Artery Systolic Pressure
11%
Pulmonary Hypertension
44%
Randomized Trial
11%
Reduced Mortality
11%
Retrospective Analysis
11%
Severe Pulmonary Hypertension
100%
Statin Therapy
100%
Statins
100%
Subgroup Analysis
11%
Survival Benefit
11%
Transthoracic Echocardiography
11%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
25%
Chronic Obstructive Lung Disease
75%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
62%
Inflammation
12%
Pulmonary Hypertension
100%
Statin (Protein)
100%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
15%
Animal Model
7%
Heart Ejection Fraction
7%
Heart Left Ventricle Function
15%
Pleiotropy
7%
Statin
100%
Systolic Blood Pressure
7%